I think it would be massively inappropriate to contact Novartis. Plus they would not be able to say anything that MSB hasn't said.
I can't believe how long this is taking but I did miss that snippet about the delay in getting the data. As I've stated before, when they have analysed the data, I expect an announcement and webinar from MSB to explain the results. Shortly after that (or perhaps in the same announcement), I would expect an update on the agreement with Novartis, whether it is closed, re-negotiated or terminated. Until then, all we can do is wait. I imagine the waiting is as frustrating for the company as it is for us.
Deadline for Novartis, page-170
-
- There are more pages in this discussion • 260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |